CORDRAN N Drug Patent Profile
✉ Email this page to a colleague
When do Cordran N patents expire, and when can generic versions of Cordran N launch?
Cordran N is a drug marketed by Lilly and is included in two NDAs.
The generic ingredient in CORDRAN N is flurandrenolide; neomycin sulfate. There are four drug master file entries for this compound. Additional details are available on the flurandrenolide; neomycin sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CORDRAN N?
- What are the global sales for CORDRAN N?
- What is Average Wholesale Price for CORDRAN N?
Summary for CORDRAN N
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| DailyMed Link: | CORDRAN N at DailyMed |
US Patents and Regulatory Information for CORDRAN N
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | CORDRAN N | flurandrenolide; neomycin sulfate | CREAM;TOPICAL | 050346-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Lilly | CORDRAN N | flurandrenolide; neomycin sulfate | OINTMENT;TOPICAL | 050345-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
